News List
More than $13M Awarded to Study Childhood Obesity Interventions in Rural and Minority Communities in Louisiana and Tennessee
Pennington Biomedical Research Center and Vanderbilt University Medical Center have received $13.8 million for five years of research funding from the Patient-Centered Outcomes Research Institute to study the ideal “dose” of behavioral interventions to treat childhood obesity in rural and minority communities across Louisiana and Tennessee.
Learn More
LA CaTS’ Community Research for Optimal Wellness Network to Host Free Open House at Pennington Biomedical Research Center
The Community Research for Optimal Wellness Network, or CROWN, is hosting a free open house to encourage members of the Baton Rouge community to discover more about the program and its services. The open house will include tours of the Pennington Biomedical facility, engaging activities, opportunities to meet esteemed scientists, and photos with Santa Claus.
Learn More
A Prophetic Vision
Every day, thousands of Baton Rouge motorists zip past the iconic Pennington Biomedical Research Center on bustling Perkins Road – the expansive campus stretching 222 acres between Quail Drive and Kenilworth Parkway. The average Capital City resident no doubt knows that important research is happening inside, but few appreciate the extent of its worldwide impact.
Learn More
Ways to Avoid Post-Thanksgiving Drowsiness with Dr. Jacob Mey
Thanksgiving is a holiday to celebrate with family, friends and food. But after consuming turkey, sides and desserts, we are often tired and ready for that holiday nap. Is tryptophan to blame? Are there other causes to the “food coma” many find ourselves in on Thanksgiving? Dr. Jacob Mey, assistant professor at Pennington Biomedical, answers those questions and provides tips for celebrating your Thanksgiving.
Learn More
LSU Science Café: Demystifying School Lunch
From mystery meat to the lunch lady, Pennington Biomedical Research Center registered dietitian Cathy Carmichael will offer insight into the challenges and joys of school lunch at the LSU Science Café, on Tuesday, Nov. 28. The event will take place from 5-7 p.m. at the Varsity Theatre, 3353 Highland Road in Baton Rouge.
Learn More$3.4 Million Investment in Baton Rouge Health District Gateway Enhancements
The U.S. Department of Commerce, via its Economic Development Administration (E.D.A.), announced a significant $4.4 million investment in Louisiana's infrastructure. This allocation is geared towards strengthening the areas recently affected by disasters. A significant portion will be directed to the Baton Rouge Health District, in collaboration with Mayor-President Sharon Weston Broome, for vital enhancements.
Learn More
The Obesity Society Past Presidents Comment on SELECT Study Results
New findings show that the medication known as Wegovy® (semaglutide) can reduce existing heart disease in patients with obesity by 20%, according to a study co-authored by past presidents of The Obesity Society (TOS) and published in The New England Journal of Medicine.
Learn More
Semaglutide Delivers 20 Percent Reduction in Major Adverse Cardiovascular Events in Patients with Obesity but No History of Diabetes
Semaglutide, the antidiabetic medication that is also used to manage weight, has been shown to deliver a reduction in major adverse cardiovascular events by up to 20 percent for those without diabetes. The drug was previously shown to reduce the risk of cardiovascular events in patients with diabetes, but recent data shows the cardiovascular benefits of the drug in those without diabetes. The Semaglutide Effects on Heart Disease and Stroke in Patients with Overweight or Obesity, or SELECT, study (NCT03574597) is one of the largest cardiovascular outcome studies in the field of obesity, with more than 17,000 participants enrolled. The study compares the effects on patients of semaglutide versus a placebo for major heart disease events and stroke.
Learn More
Pennington Biomedical to Conduct Glycemic Control Study for Patients Living with Diabetes
Pennington Biomedical researchers, led by Associate Executive Director of Population and Public Health Sciences, Dr. Peter Katzmarzyk, with support from WeightWatchers, will launch a study to evaluate a behavioral weight management program with the use of a continuous glucose monitor, or CGM, in individuals with Type 2 diabetes.
Learn More
Elite Faculty Accomplishments Celebrated at LSU Presidential Laurel Event
In its second year, this event highlights the exceptional academic, creative, and research accomplishments of faculty from all eight LSU institutions over the last academic year. This award is very selective, with a goal of highlighting the exceptional stature of our collective faculty in their respective fields while celebrating success and encouraging aspiration among peers.
Learn More
